Law Professor Nails Why Judge Merchan Is Sentencing Trump on January 10
The Latest Development on the Tesla Cybertruck Bomber Just Took an Unusual Turn
We Know When Trump Will Be Sentenced in Hush Money Case
Turns Out Trump Had More to Do With Speaker Mike Johnson's Victory Than...
The Main Takeaway From Judge Merchan's Latest Decision Regarding Trump's 'Hush Money' Case
The Department of Government Efficiency (DOGE) Will Succeed
The West Does Not Even Know That It Is Committing Suicide
Kristi Noem: The Homeland Security Director America Needs
Brace Yourselves for the Left’s Coming Rage
These Nine Republicans Already Have Plans to Oust Mike Johnson
JD Vance Is All Smiles As Kamala Harris Swears in New Senators
Meta Replaces Its Global Head of Policy With a Republican
Here's What Republicans Are Saying About Mike Johnson's Speakership Win
Border Patrol Issues a Grim Warning to Migrants Ahead of Inauguration Day
Trump Responds to Biden Giving Award to Liz Cheney
Tipsheet

The CDC Director Just Gave Us an Updated Vaccine Timeline

AP Photo/Alex Brandon

We've brought you a lot of exciting vaccine news these past few weeks. And there's more of it on Tuesday. Center for Disease Control Director Robert Redfield said Americans should expect a vaccine to be rolled out very, very soon. He predicted the second week of December.

Advertisement

The next question then is, who will be receiving the first doses. He answered that too.

In an interview with Fox News anchor Dana Perino, Redfield shared that the first groups to get the vaccine will probably be "nursing home residents and then some combination of health care providers and individuals at high risk for a poor outcome."

"I do think we'll have about 40 million doses of vaccine before the end of the...year," Redfield continued. "That's enough to vaccinate 20 million people. But then it will continue through January and February and hopefully by March we'll start to see vaccine available for the general public."

Advertisement

Pfizer, who vaccine its been developing with BioNTech has produced a 95 percent efficacy rate, requested an emergency authorization from the FDA. A second vaccine candidate being produced by Moderna isn't too far behind, reporting a 94 percent effectiveness. And then a third, developed by AstraZeneca, is up to 90 percent effective.

The FDA has reportedly scheduled a meeting for Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's request.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement